2Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs[J]. JAMA, 2004, 292 (21) : 2585-2590.
3Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement[J]. Lancet, 1986, 1 (8476) :307-310.
4Blann AD, Seigneur M, Steiner M, et al. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events[J]. Thrombosis and haemost, 1998, 79 (6) : 1080-1085.
6Vandermeeren M, Janssens S, Wouters H, et al. Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-r, B1, but not RelA in normal human dermal fibroblast cells[J]. J Invest Dermatol, 2001, 116 (1) :124-130.
7Gawaz M, Neumann F J, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells[J] Circulation, 1998, 98(12) : 1164-1171.
8Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies[J]. BMJ, 2012, 346 : e7492.
9Zhang P, Ozdemir T, Chung CY, et al. Sequential binding of αVI33 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophils[J]. J Immunol, 2011,186 (1) 242-254.
